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ABSTRACT
Ten indole alkaloids were obtained from the marine sponge-associated fungus Neosartorya siamensis KUFA 0017. We studied
the antimicrobial properties of these and of three other compounds previously isolated from the soil fungus N. siamensis
KUFC 6349. Only neofiscalin A showed antimicrobial activity against Gram-positive bacteria, including methicillin-resistant
Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VRE); with a minimum inhibitory concentration
(MIC) of 8 μg mL−1 against both strains. Another compound, fiscalin C, presented synergistic activity against MRSA when
combined with oxacillin, although alone showed no antibacterial effect. Moreover, neofiscalin A, when present at sub-MICs,
hampered the ability of both MRSA and VRE strains to form a biofilm. Additionally, the biofilm inhibitory concentration
values of neofiscalin A against the MRSA and VRE isolates were 96 and 80 μg mL−1, respectively. At a concentration of
200 μg mL−1, neofiscalin A was able to reduce the metabolic activity of the biofilms by ∼50%. One important fact is that our
results also showed that neofiscalin A had no cytotoxicity against a human brain capillary endothelial cell line.
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INTRODUCTION
The emergence and dissemination of antimicrobial resistance
among bacteria threaten the usefulness of currently available
antibiotics to treat infections. Multidrug-resistant strains,
such as methicillin-resistant Staphylococcus aureus (MRSA),
vancomycin-resistant Enterococcus faecalis (VRE), extended-
spectrum beta-lactamase and carbapenamase-producing
Enterobacteriaceae, are causes of significant concern not only
due to high levels of resistance to antibiotics, but also due to
the associated costs and human deaths that occur worldwide
each year (Woodford and Livermore 2009; Lee Ventola 2015).
There is, therefore, an urgent need for developing new and
more effective antibiotics (Butler, Blaskovich and Cooper 2013).
Nature, itself, has been a source of antibiotics (Butler and
Buss 2006). Based on this premise, our study focused on the
identification of new potential antibiotics derived from terres-
trial and marine-fungi of the genus Neosartorya. Several indole
alkaloids have already been isolated from these fungi (Javasuriya
et al. 2009; Yang et al. 2010; Kijjoa et al. 2011; Buttachon et al. 2012;
Eamvijarn et al. 2012, 2013); however, none was tested for its an-
timicrobial activity.
Our work focuses on the study of the chemical constituents
of two fungi, Neosartorya siamensis KUFA 0017 and N. siamensis
KUFC 6349, which are deposited in a Thai collection in order to
assess their antibacterial activity and their synergism with cur-
rently used antibiotics against multidrug-resistant bacteria.
MATERIALS AND METHODS
Fungi and extraction of secondary metabolites
Neosartorya siamensis (KUFA 0017) was isolated from the sea fan
Rumphella spp., collected at a depth of 10m from the coral reef of
the Similan Islands (8˚39´09˝N, 97˚38´27˝E), Phang Nga Province,
Southern Thailand, in 2010. The fungus was identified, and pure
cultures were deposited as KUFA 0017 in the Fungal Collection
of the Faculty of Agriculture at Kasetsart University in Bangkok,
Thailand. The fungusN. siamensisKUFC 6349,whichwas isolated
from forest soil at Samaesarn Island, Chonburi Province, Thai-
land, in November 2008, described by Buttachon et al. (2012) is
also part of the same collection.
The general experimental procedures used in the extrac-
tion of secondary metabolites from N. siamensis KUFC 0017
were previously described (Buttachon et al. 2012; Gomes et al.
2014), resulting in the isolation of the indole alkaloids 3′-
(4-oxoquinazolin-3-yl) spiro[1H-indole-3,5′-oxolane]-2, 2′-dione
(1), nortryptoquivaline, tryptoquivaline (2), tryptoquivalines L
(3), H (4) and F (5), fiscalin A (7), epi-fiscalin A (8), neofiscalin A
(9), epi-neofiscalin A (10) and epi-fiscalin C (12) (Fig. 1), in addition
to 2,4-dihydroxy-3-methylacetophenone and chevalone C. Com-
pounds 1–5, 7–10 and 12 were evaluated together with trypto-
quivaline O (6), fiscalin C (11) and sartorymensin (13), previously
obtained from the soil fungusN. siamensis KUFC 6349 (Buttachon
et al. 2012).
Bacterial strains, antimicrobial susceptibility testing
and synergistic studies
The assays conducted using various bacterial strains (Escherichia
coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, Staphylo-
coccus aureus ATCC 25923, Enterococcus faecalis ATCC 29212, S.
aureus B1 and E. faecalis W1) to assess the antimicrobial prop-
erties of the compounds and their synergistic and antibiofilm
activities have previously been described (Gomes et al. 2014).
To assess the combined effect between the compounds and
particular antibiotics, a screening susceptibility test using the
disk diffusion method was conducted against two multidrug-
resistant isolates, S. aureus B1 (a MRSA isolate) and E. faecalis
W1 (a VRE isolate). Then, based on the results of that assay,
the synergy between fiscalin C (11) and oxacillin or ampicillin
(Sigma-Aldrich, St. Louis, MO, USA) was tested using a broth
microdilution checkerboard method against the MRSA isolate
(S. aureus B1). The determination of the minimum inhibitory
concentration (MIC) using the microdilution method and the
synergy assessment between compounds and antibiotics using
the checkerboard method were performed in three independent
experiments. The interpretation of the results obtained from the
checkerboard assay was based on the calculation of the frac-
tional inhibitory concentration (FIC) index (FIC), which is the
sum of the FIC of each drug. Thus, the FIC of drug A (FIC A)
equaled the sum of MIC of drug A when in combination divided
by the MIC of drug A alone, and the FIC of drug B (FIC B) equaled
the MIC of drug B when in combination divided by the MIC of
drug B alone. According to Odds (2003), a value of FIC ≤ 0.5 is
indicative of synergic properties; 0.5 < FIC ≤ 4 means there is
no interaction, and a value of FIC > 4 indicates antagonism.
Evaluation of the antibiofilm activity of neofiscalin A (9)
The inhibition of biofilm formation in the presence of ne-
ofiscalin A (9) was evaluated through the crystal violet assay.
Various concentrations of neofiscalin A were tested (2× MIC,
MIC, 1/2× MIC and 1/4× MIC) in two independent experiments
carried out in triplicate for each of the concentrations. The
statistical significance of the difference between controls and
experimental groupswas calculated using Student’s t-test. P val-
ues < 0.05 are considered statistically significant. A microscopic
analysis (fluorescence microscopy) of the biofilms of S. aureus
B1 and E. faecalis W1 in the presence of the MIC and 1/4× MIC
of neofiscalin A (9) was conducted, after staining the biofilms
with the appropriate mixture of SYTO 9 and propidium iodide
(LIVE/DEAD BacLight Bacterial Viability Kit—Life Technologies—
Molecular Probes, Carlsbad, CA, USA).
The biofilm inhibitory (BIC) and biofilm eradication (BEC)
concentrations were determined through two independent ex-
periments. The metabolic activity of 24-h biofilms formed by S.
aureus B1 (MRSA) and E. faecalis W1 (VRE) after treatment with
neofiscalin A (9) for an additional period of 24 h was assessed in
a single experiment using the 3-(4,5-dimethylthiazole-2-yl)-2,5-
diphenyl tetrazolium bromide (MTT) assay (Trafny et al. 2013).
Cytotoxicity assay for neofiscalin A (9)
The cytotoxicity of neofiscalin A (9) was evaluated using a cul-
ture of the human brain microvascular endothelial cell line
hCMEC/D3, as previously described (Alves et al. 2015). Two exper-
iments were conducted in triplicate and then averaged. In brief,
1% dimethyl sulfoxide (DMSO) was used as the negative control
and 1% Triton X-100 as the positive control. Cytotoxicity was ex-
pressed as a percentage of cell viability, assuming 100% viability
in the negative control.
RESULTS AND DISCUSSION
None of the compounds (Fig. 1) showed activity against the
Gram-negative strains tested (MIC values higher than 256 μg
mL−1). However, neofiscalin A (9) presented antibacterial activity
Figure 1. Secondary metabolites from N. siamensis KUFA 0017 (1–5, 7–10, 12) and from the soil fungus N. siamensis KUFC 6349 (6, 11 and 12) (Buttachon et al. 2012).
against Gram-positive bacteria, showing a low MIC (8 μg mL−1)
against all strains of Staphylococcus aureus and Enterococcus fae-
calis. The minimum bactericidal concentration of neofiscalin A
(9) was usually four times greater than the MIC (32 μg mL−1);
however, it was of 16 μg mL−1 against S. aureus ATCC 25923.
These results attest the potential of neofiscalin A (9) to combat
multidrug-resistant Gram-positive bacteria such as MRSA and
VRE.
The analysis of the chemical structure of fiscalin A (7), epi-
fiscalin A (8), neofiscalin A (9) and epi-neofiscalin A (10) revealed
that they are diastereoisomers, differing from each other only in
the absolute configuration of C-3 and C-22. However, the struc-
tures of the epimeric fiscalin C (11) and epi-fiscalin C (12) have
two methyl groups instead of one methyl group on C-22, as in
the structures of the fiscalin A series. The fact that only neofis-
calin A (9) was active among the fiscalin analogs suggests that
not only the substituent on C-22 (one methyl group) but also the
stereochemistry of C-3 and C-22 (3R, 22R) may be required for
antibacterial activity.
Regarding the synergistic effects inferred from the combi-
nation of compounds 1–13 with antibiotics to which the tested
bacteria were resistant, it was observed (through the disk dif-
fusion method) that fiscalin C (11) exhibited potential synergy
with both ampicillin and oxacillin against the MRSA isolate (S.
aureus B1). When not in combination, neither fiscalin C (11),
ampicillin nor oxacillin produced any zone of inhibition on agar
plates. However, when fiscalin C (11) was used in combination
with ampicillin and oxacillin an inhibition zone was observed,
of 8 and 10 mm, respectively. The checkerboard assay was per-
formed by combining each antibiotic (ampicillin or oxacillin)
with fiscalin C (11). Thus, from the FIC index values shown in
Table 1 it can be observed that the association of fiscalin C (11)
with oxacillin showed a synergistic effect (FIC index< 0.5), while
the combination with ampicillin was indifferent (0.5 < FIC in-
dex ≤ 4) (Odds 2003). These results may indicate that fiscalin C
(11) and oxacillinmay somehow interact. This interaction needs
to be further studied to identify how the synergy occurs. Note-
worthy, the structural features required for such synergymay be
different from those needed for antibacterial activity. As only fis-
calin C (11) exhibited a synergistic effect, it might be concluded
that the presence of two methyl groups on C-22 and the 3S con-
figuration are required for this activity.
Table 1. MIC values of fiscalin C (11) in combination with oxacillin and ampicillin and respective FIC index values obtained from the checker-
board method.
MIC (μg mL−1)
Strain 11 OX alone 11 with OX OX with 11 FIC Index
S. aureus B1 > 512 128 16 16 <0.156
11 alone AMP alone 11 with AMP AMP with 11
S. aureus B1 > 512 128 512 128 >1
11: fiscalin C (11); OX: oxacillin; AMP: ampicillin; FIC index < 0.5: synergy.
Figure 2. Biomass quantification through the crystal violet assay of biofilms
formed by Gram-positive bacteria in presence of neofiscalin A (9). Biofilms were
formed in the presence of different concentrations (ranging from 2× MIC to 1/4×
MIC) of neofiscalin A (9). Error bars represent SD. Asterisks indicate that the dif-
ference between the concrete condition and the control is statistically significant
(P < 0.05).
The effect of neofiscalin A (9) on the biofilm formation ca-
pability of S. aureus and E. faecalis was assessed at diverse con-
centrations (2× MIC, 1/2× MIC and 1/4× MIC) through biomass
quantification after crystal violet staining. The results are shown
in Fig. 2. At 2× MIC and MIC of neofiscalin A (9), none of the
strains was able to form a biofilm. At the sub-inhibitory concen-
tration of 1/2× MIC, a small increase in the biomass was verified
but the strains did not formmuch biofilm. A lower sub-inhibitory
concentration of 1/4× MIC allowed the formation of a larger
biofilm, but smaller than that observed in the control group. In
order to deepen the study of the effect of this compound on
biofilm formation, a microscopic observation of the biofilm was
performed by means of the live/dead staining method (Fig. 3). In
the presence of neofiscalin A (9), at its MIC value, no growth and,
consequently, no biofilm was produced (Fig. 3b). Nevertheless,
at the concentration of 1/4× MIC a biofilm was formed (Fig. 3c),
though it was not as large as in the control (Fig. 3a). In contrast,
the sub-inhibitory concentrations of antibiotics, to which bac-
teria were continuously exposed, have been reported to greatly
increase the biofilm formation (Hoffman et al. 2005).
The BIC values of neofiscalin A (9) against 24-h biofilms of S.
aureus B1 and E. faecalisW1were 96 and 80 μgmL−1, respectively,
but the BEC values were higher than 25× MIC, i.e. 200 μg mL−1
for both strains. Nevertheless, neofiscalin A (9) showed great po-
tential in interfering with the viability of preformed biofilms of
S. aureus and E. faecalis. Flemming et al. (2009) have shown that
24-h preformed staphylococcal biofilms subjected to treatment
with 500 μg mL−1 of tetracycline were not eradicated, as most of
the cells within the biofilms remained viable.
Figure 3. Microscopic visualization of 24-h biofilms formed in presence of neofiscalin A (9), after live/dead viability staining. Biofilm formation by S. aureus B1 (MRSA)
and E. faecalis W1 (VRE) in absence (a), in presence of the MIC (b) and 1/4× of the MIC (c) of neofiscalin A (9).
The metabolic activity of 24-h biofilms of S. aureus B1 and E.
faecalis W1 treated for another 24 h with 200 μg mL−1 of neofis-
calin A (9) was reduced by nearly 50% (Fig. S1, Supporting Infor-
mation).
No cytotoxicity was shown by neofiscalin A (9) at concentra-
tions of 5, 10 and 20 μg mL−1 against a human brain endothelial
cell line (hCMEC/D3). In other words, the percentage of cell vi-
ability was equal or greater than the viability obtained in the
negative control, DMSO (Fig. S2, Supporting Information).
In conclusion, the marked antimicrobial activity (MIC = 8 μg
mL−1) of neofiscalin A (9) against MRSA and VRE strongly sug-
gests that this natural product is a prime candidate for further
chemical modifications aimed at the improvement of the an-
tibacterial spectrum (changing peripheral chemical groups), as
well as for additional in vivo tests to evaluate its efficacy, phar-
macology and safety. Its potential as an antibiofilm agent should
be pursued. Furthermore, fiscalin C (11) must be explored as an
adjuvant in antimicrobial combined therapeutics.
The continued emergence of multidrug-resistant bacteria
has drawn increasing attention in recent years. Currently, how-
ever, the main strategy used to combat the dearth of new effec-
tive antibiotics relies on the chemical modification of known an-
tibiotics. If this approach fails, new classes of compounds that
originate from natural sources can have great potential in re-
search and development of new antibiotics.
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